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Abstract Mitogen-activated protein kinase phosphatase 1
(MKP-1) is negatively regulating mitogen-activated protein
kinases and is therefore involved in early signaling processes.
The expression of the mkp-1 gene is induced by growth factors
and stress. The promoters of the human and murine mkp-1 genes
contain several conserved DNA binding elements, including two
cAMP response elements and an E box. We observed that the
upstream stimulatory factor (USF), but not c-Myc, activated
mkp-1. USF synergized with protein kinase A, thus providing
evidence for a role of the E box, during signal-regulated
stimulation of mkp-1.
z 2000 Federation of European Biochemical Societies.
Key words: Mitogen-activated protein kinase;
Mitogen-activated protein kinase phosphatase 1; Upstream
stimulatory factor; Myc; Protein kinase A; Signaling
1. Introduction
Early cellular signal transduction in response to serum
growth factors is characterized by the rapid activation of dif-
ferent kinases, including mitogen-activated protein kinase
(MAPK) family members and protein kinase A (PKA) [1,2].
These kinases phosphorylate several transcription factors that
translate the incoming signals into regulation of gene tran-
scription. The activities of MAPKs are opposed by MAPK
phosphatases (MKPs). MKPs are dual speci¢city phospha-
tases that inactivate MAPKs by dephosphorylating both
Thr and Tyr residues within their signature sequence [3].
Thus MKPs are negative regulators of MAPK-dependent sig-
naling. The analysis of MKP-1, the ubiquitously expressed
founding member of this family of phosphatases, revealed
that it can e⁄ciently dephosphorylate p42/44MAPK (ERK1
and ERK2, respectively) in vitro and in vivo [4^6]. In addi-
tion, overexpression of MKP-1 blocks entry into the S phase
and the expression of genes that are stimulated by p42/
44MAPK [7]. Thus, these ¢ndings suggest that MKP-1 antago-
nizes the function of p42/44MAPK. In support, the inhibition of
MKP-1 expression leads to a sustained activation of p42/
44MAPK [8^10].
The mkp-1 gene, originally named erp/3CH134 or CL100,
was ¢rst identi¢ed because it is induced by growth factors and
stress [11^13]. Furthermore, it was demonstrated that PKA,
Ca2 and, to a lesser degree, protein kinase C (PKC) contrib-
ute to the activation of mkp-1 [9^11,13]. In particular cholera
toxin and the phosphodiesterase inhibitor isobutylmethylxan-
thine, which both elevate intracellular cAMP levels, strongly
induce the expression of murine mkp-1 [11,13]. PDGF-stimu-
lated induction of MKP-1 was also abolished by a PKA in-
hibitor (PKI) [14]. Furthermore, Ca2 was identi¢ed to play
an essential role in the activation of mkp-1 expression [10,15].
An increase in the level on intracellular Ca2 leads to the
stimulation of Ca2/calmodulin-dependent kinases which in
turn can activate transcription factors that bind to cAMP
response elements (CRE) [16]. Together these ¢ndings suggest
that mkp-1 is regulated via the cAMP signal transduction
pathway. In addition, activation of p42/44MAPK is important
in stimulating the expression of MKP-1 [9,10].
Comparison of the 5P £anking sequences of the murine and
human mkp-1 genes revealed a high degree of sequence ho-
mology in the proximal promoter region (roughly the ¢rst 250
nucleotides). Most notable are the presence of several con-
served consensus sequences that include two CREs and one
E box motif (Fig. 1) [13,17]. Further distal promoter regions
show little homology. The analysis of the human mkp-1 pro-
moter demonstrated that a fragment of 800 bp, including the
conserved region, was responsive to serum [17]. However, nei-
ther the human nor the murine mkp-1 promoters contain se-
rum response elements as found in many immediate early
genes [18]. This suggests that the di¡erent stimuli described
above, including p42/44MAPK, work through the CREs.
Since the induction pro¢le of mkp-1 and c-myc are compar-
able in response to serum [11,13,19,20], we were interested in
determining whether c-Myc participates in the regulation of
the mkp-1 promoter. c-Myc is a member of the basic region/
helix^loop^helix/leucine zipper (bHLHZip) family of tran-
scriptional regulators that interact with E box elements with
the core sequence 5P-CACGTG (referred to as Myc E box)
[21]. Several Myc-responsive genes have been identi¢ed that
all contain E box DNA elements [22]. Our ¢ndings reveal that
c-Myc cannot transactivate the mkp-1 promoter. Instead up-
stream stimulatory factor (USF), a ubiquitously expressed
bHLHZip protein that binds to Myc E boxes, was found to
activate the mkp-1 promoter. Furthermore, USF cooperated
with signals that stimulate CRE-dependent transcription.
These ¢ndings identify a novel cooperativity between CRE-
and E box-mediated transcription.
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2. Materials and methods
2.1. Cells and plasmids
COS-7 cells were cultivated in Dulbecco’s modi¢ed Eagle’s medium
and RK-13 cells in modi¢ed Eagle’s medium, both supplemented with
1% penicillin/streptomycin and 10% fetal calf serum. pSP-maxp22,
pCMV-hu-c-myc, and pM4-min-tk-luc, containing four Myc E boxes,
have been described previously [23]. pCKEV encodes the K isoform of
the catalytic subunit of PKA and was a kind gift from G.S. McKnight
[24]. A plasmid encoding PKI was obtained from R.A. Maurer [25],
the reporter p(Gal)4-mintk-luc from R. Janknecht [26] and plasmids
encoding Gal4-USF, human USF1 (pUHD-USF1) and a USF1 mu-
tant with a deletion of the basic region (pUHD-USF1mutBR) from
M. Eilers [27] and Gal4-Myc(1^262) from C. Dang [28].
2.2. mkp-1 luciferase reporter constructs
A 255 bp long fragment from 3245 to +10 of the murine mkp-1
promotor which shows the highest sequence homology compared to
the human mkp-1 promotor [13,17] was ampli¢ed with the primers
3CH-BamHI-FW (5P-CGGGATCCGGACAGGAGGGTGGGGGC-
CG-3P) and 3CH-SalI-REV (5P-GAAGATCTGTCCTTCACTGCG-
CTGCCGTC-3P) on murine genomic DNA (kind gift of R. Lesche).
The promoter fragment was cloned into the luciferase vector Xp-1 [29]
and sequenced, resulting in the construct mu-mkp-1-luc. pGL3-151-luc
comprises a 190 bp long fragment of the hu-mkp-1 promotor from
3179 to +11, referred to as hu-mkp-1-luc.
2.3. Transient transfections and electrophoretic mobility shift assays
(EMSAs)
Transient transfections were performed using a standard calcium
phosphate protocol as described previously [30,31]. All experiments
were performed in duplicate or triplicate, repeated at least three times
and standardized for coexpressed L-galactosidase activity. EMSAs
were carried out as described previously [30]. The following oligonu-
cleotides were used (the E box core sequences are underlined): CMD:
5P-TCA GAC CACGTG GTC GGG; hu-mkp-1 E box: 5P-CCC CGT
CACGTG ATC ACC (3105 to 388 in Fig. 1) and mu-mkp-1 E box:
5P-CCC GGT CACGTG TCT GCC (3126 to 3109 in Fig. 1).
3. Results
3.1. The mkp-1 promoter is responsive to USF but not to
c-Myc
The human and murine mkp-1 promoter possess a con-
served E box (Fig. 1). Therefore, we analyzed whether these
promoters are transcriptional targets for members of the
bHLHZip family of transcription factors, in particular for c-
Myc/Max and USF. In transient transfection experiments in
RK-13 cells USF transactivated reporter gene constructs that
contain the murine or human promotor in a dose-dependent
fashion whereas c-Myc was inactive and Max resulted in a
low level of activation (Fig. 2). In control experiments the
standard Myc E box reporter M4-mintk-luc was activated
by both c-Myc and USF and repressed by Max as described
previously [23,32^35]. Thus, under standard transient trans-
fection conditions c-Myc could not activate the mkp-1 pro-
moters. The lower level of stimulation of the mkp-1-derived
reporters by USF1 in comparison to the arti¢cial promoter
Fig. 1. Sequence alignment with Clustal W of the mu-mkp-1 (GenBank accession number S64851) [13] and the hu-mkp-1 promotors (GenBank
accession number U01669) [17]. The conserved DNA binding motifs of the E box, the two CRE sites and the TATA box have been highlighted
in the sequence. Asterisks identify identical nucleotides. Arrow heads indicate the transcriptional start sites: the shaded arrow heads indicate
the two G nucleotides identi¢ed by Lewis and Keyse (data not shown), the ¢lled arrow heads indicate the site mapped by Kwak et al. [17] of
the hu-mkp-1 gene and the open arrow head indicates a potential start site of the mu-mkp-1 gene [13].
Fig. 2. USF but not c-Myc transactivates the mu-mkp-1 and hu-
mkp-1 promotors. RK-13 cells were transiently transfected with 1 Wg
of mu-mkp-1-luc (left panel), hu-mkp-1-luc (middle panel) or M4-
mintk-luc (right panel) in combination with the indicated amounts
of expression plasmids coding for USF1, c-Myc or Max p22. The
activities of the reporter plasmids in the absence of any coexpressed
e¡ector proteins were set as 1.
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construct M4-mintk-luc is most likely due to the presence of
only one E box in the former constructs whereas the latter
contains four E boxes.
3.2. Poor binding of c-Myc/Max complexes to mkp-1-derived
E boxes
Several studies have shown that the £anking sequences of
E boxes a¡ect the degree of binding by c-Myc/Max com-
plexes, whereas USF/USF and Max/Max complexes are less
sensitive. The sequences £anking the E boxes of the human
and murine mkp-1 promoters are conserved on the 5P side but
not on the 3P side and, more importantly, these £anking se-
quences do not match high a⁄nity consensus sequences (Fig.
1) (for review see [21]). Therefore, we studied in vitro DNA
binding of COS-7-derived c-Myc/Max, Max/Max and USF1/
USF1 complexes to oligonucleotides containing E boxes de-
rived from the mu- and hu-mkp-1 promotor in comparison to
a high a⁄nity c-Myc E box as in CMD (Fig. 3). The binding
of the di¡erent complexes was assessed by using the three
oligonucleotides as probes and by performing competition
experiments with the same oligonucleotides. USF bound
with a similar a⁄nity to all three oligonucleotides (Fig. 3A^
C, right panels). In contrast the binding of c-Myc/Max and, to
a lesser degree, of Max/Max to mu-mkp-1 and more signi¢-
cantly to hu-mkp-1 was reduced compared to CMD (Fig. 3A^
C, left panels). c-Myc/Max complexes were competed best
with cold CMD followed by the mu-mkp-1 and then the
hu-mkp-1 E box, whereas for USF1/USF1 CMD competed
only marginally better than either the mu- or the hu-mkp-1
E box. This reduced DNA binding activity of c-Myc/Max
complexes to the E boxes derived from the mkp-1 promoters
is most likely su⁄cient for their inability to transactivate the
mkp-1 promoters as shown above.
3.3. USF and PKA cooperate in transactivation of the murine
mkp-1 promoter
Not only the E box but also two CRE sites are conserved
between the human and murine mkp-1 promoters and multi-
ple lines of evidence point to a role of the CREs in the reg-
ulation of the mkp-1 genes by several di¡erent signal trans-
duction pathways as summarized above. Therefore, we tested
whether the mu-mkp-1 promoter could be regulated by PKA.
Coexpression of the catalytic subunit of PKA stimulated the
activity of the promoter (Fig. 4A). Next we addressed the
question whether PKA and USF cooperate on the mu-mkp-
1 promoter. Coexpression of di¡erent amounts of PKA and
USF resulted in a synergistic activation of the reporter con-
struct (Fig. 4A). The response to PKA was inhibited by a
Fig. 3. DNA binding activity and a⁄nity of COS-7-derived c-Myc/Max, Max/Max and USF1/USF1 complexes to oligonucleotides encompass-
ing the E boxes of the hu- and mu-mkp-1 promotors and the high a⁄nity c-Myc E box oligonucleotide CMD. The following radioactively-la-
beled oligonucleotides were used: hu-mkp-1 E box (A); mu-mkp-1 E box (B) and CMD (C). The panels on the left show EMSAs with COS-7-
derived c-Myc/Max and Max/Max complexes, the panels on the right show EMSAs with COS-7-derived USF1/USF1 complexes. (C) indicates
control lanes where oligonucleotide probes without cell extracts were analyzed. Competition experiments were carried out with 5-fold, 50-fold
and 500-fold excess of cold oligonucleotides as indicated. The free probes were run o¡ the bottom of the gel for better separation of the pro-
tein^DNA complexes.
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dominant negative USF1 that lacks the DNA binding domain
(Fig. 4B). Cooperativity with USF was also seen by stimulat-
ing endogenous PKA with forskolin, an adenylate cyclase
agonist (Fig. 4C). Furthermore, coexpression of a PKI inhib-
ited the activation of the mu-mkp-1 promoter by USF (Fig.
4A). Transactivation through CREs is enhanced by CBP [1].
In agreement the cooperativity between PKA and USF was
enhanced by CBP (Fig. 4D). Together these ¢ndings demon-
strate that PKA-regulated factors cooperate with USF to syn-
ergistically activate the mkp-1 promoter.
To address whether PKA directly regulated USF, its activ-
ity was measured in the presence or absence of coexpressed
PKA on M4-mintk-luc, a reporter that contains four E boxes
but no CRE. Transactivation by USF was not a¡ected by
PKA (Fig. 5A). Similarly, transactivation through the USF
transactivation domain fused to the heterologous DNA bind-
ing domain of Gal4 was not responsive to PKA (Fig. 5A).
These ¢ndings suggest that the cooperativity of PKA with
USF is not due to direct regulation of USF by PKA but
rather through activating CRE binding factors.
c-Myc was unable to activate the mkp-1 promoter. However
it remained open whether c-Myc can synergize with PKA.
Therefore we coexpressed c-Myc with PKA and measured
transactivation of mu-mkp-1-luc and M4-mintk-luc reporters
(Fig. 5A). c-Myc did not alter the response of mu-mkp-1-luc
to PKA and consistently PKA did not a¡ect c-Myc-dependent
activation of M4-mintk-luc. Similarly the activity of Gal4-
Myc, a fusion protein of the Myc transactivation domain
and the Gal4 DNA binding domain, was not a¡ected by
PKA (Fig. 5A). These ¢ndings support the notion that c-
Myc is not directly involved in the transcriptional regulation
of the mkp-1 gene.
4. Discussion
Comparing the promotors of the murine and human genes
coding for MKP-1 revealed a conserved Myc consensus E box
and two conserved CRE sites (Fig. 1). We were interested in
determining whether c-Myc is involved in regulating the ex-
pression of mkp-1. Expression of mkp-1 mRNA and protein
was stimulated as early as 30 min and 1 h, respectively, after
applying di¡erent stimuli [9,11^13]. The expression of c-myc
occurs with similar kinetics [19,20]. However c-Myc was un-
able to stimulate the mkp-1 promoters (Fig. 2). This is, at least
in part, the result of low DNA binding activity towards E
boxes derived from either the human or the murine mkp-1
promoters (Fig. 3). These experimental ¢ndings are in agree-
ment with sequence comparisons of mkp-1 E boxes with pre-
viously identi¢ed favorable and unfavorable sites for c-Myc/
Fig. 4. USF cooperates with PKA in transactivating mu-mkp-1-luc.
A: RK-13 cells were transiently transfected with mu-mkp-1-luc (1
Wg) with the indicated amounts of expression plasmids encoding
USF1, the catalytic subunit of PKA or PKI as indicated in the ¢g-
ure. B: RK-13 cells were transfected as in (A) with the indicated
amounts of expression plasmids for the catalytic subunit of PKA
and USF1mutBR. C: RK-13 cells were transiently transfected with
mu-mkp-1-luc (1 Wg), with or without 1 Wg of pUHD-USF1. The
cells were treated with 10 WM forskolin as indicated 14 h prior to
harvest. D: RK-13 cells were transfected as in (A) with expression
plasmids for USF1 (1 Wg), PKA (0.5 Wg) and CBP (2 Wg) as indi-
cated.
Fig. 5. USF and c-Myc are not targeted by PKA. RK-13 cells were
transiently transfected with 2 g of mu-mkp-1-luc (top panel), M4-
mintk-luc (middle panel) or (Gal)4-mintk-luc (bottom panel). Ex-
pression plasmids for the following proteins were cotransfected as
indicated: USF1 (1 g), the catalytic subunit of PKA (1 Wg), c-Myc
(1 Wg), Gal4-USF (1 Wg) and Gal4-Myc (0.1 Wg). The control was
set as 1 in each panel.
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Max binding (for review see [21]). While the core motif of
both mkp-1 E boxes is identical to the consensus (i.e. 5P-
CACGTG), the £anking sequences are unfavorable for
c-Myc/Max binding. In particular the position next to the
core is important to de¢ne high a⁄nity binding. While 5P-
CCACGTGG provides a high a⁄nity site, 5P-TCACGTGA,
as found in hu-mkp-1, binds poorly to c-Myc/Max. In con-
trast USF/USF complexes bind to both sequences with similar
a⁄nity [36] which is con¢rmed by our EMSA analysis (Fig.
3).
From the proposed elements in the mkp-1 promoter only
the CREs are readily categorized as elements that can respond
to di¡erent signaling cascades. In particular the responses to
increases in Ca2 and cAMP are mediated at least in part
through CREs, but also the activation of MAPKs, e.g. by
stimulating RSK2, can signal through CREs [16,37]. Thus,
it is likely that proteins binding to CREs are targets of all
di¡erent signaling cascades that have been shown to induce
mkp-1 expression. In contrast USF is a constitutively and
ubiquitously expressed transcription factor. Little is known
about its regulation by signaling cascades. However, recent
¢ndings have shown that USF is a phosphoprotein [38] that
may be regulated in response to cadmium and H2O2 [39]. In
addition USF1 has been shown to cooperate with interferon-
Q-activated STAT1 in stimulating the expression of the MHC
class II transactivator gene cIITA [40]. In the case of the gene
encoding the K7 subunit of the K-bungarotoxin-sensitive nic-
otinic acetylcholine receptor, USF cooperates with the early
growth response gene transcription factor Egr-1, which is also
targeted by phorbol ester signaling [41,42]. Together with our
¢ndings that USF1 cooperates with PKA in the activation of
mkp-1, it appears that USF plays a role in several di¡erent
signaling processes. It is possible that in all these situations
USF is a constitutively present cooperating factor that pro-
motes and facilitates transactivation by factors that are end-
points of signaling cascades, which is consistent with our ¢nd-
ing that PKA does not directly regulate USF.
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